PuraPharm Corporation Limited 1498.HK Stock
PuraPharm Corporation Limited Price Chart
PuraPharm Corporation Limited 1498.HK Financial and Trading Overview
| PuraPharm Corporation Limited stock price | 0.79 HKD |
| Previous Close | 0.98 HKD |
| Open | 0.98 HKD |
| Bid | 0.98 HKD x 0 |
| Ask | 1.03 HKD x 0 |
| Day's Range | 0.97 - 1.03 HKD |
| 52 Week Range | 0.89 - 1.66 HKD |
| Volume | 2K HKD |
| Avg. Volume | 40.88K HKD |
| Market Cap | 407.77M HKD |
| Beta (5Y Monthly) | 0.39157 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.27 HKD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | May 31, 2017 |
| 1y Target Est | N/A |
1498.HK Valuation Measures
| Enterprise Value | 814.48M HKD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.9100694 |
| Price/Book (mrq) | 1.5749235 |
| Enterprise Value/Revenue | 1.818 |
| Enterprise Value/EBITDA | -19.341 |
Trading Information
PuraPharm Corporation Limited Stock Price History
| Beta (5Y Monthly) | 0.39157 |
| 52-Week Change | -31.94% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.66 HKD |
| 52 Week Low | 0.89 HKD |
| 50-Day Moving Average | 1.04 HKD |
| 200-Day Moving Average | 1.11 HKD |
1498.HK Share Statistics
| Avg. Volume (3 month) | 40.88K HKD |
| Avg. Daily Volume (10-Days) | 33.6K HKD |
| Shares Outstanding | 395.9M |
| Float | 262.81M |
| Short Ratio | N/A |
| % Held by Insiders | 53.10% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -26.82% |
| Operating Margin (ttm) | -15.23% |
| Gross Margin | 58.63% |
| EBITDA Margin | -9.39% |
Management Effectiveness
| Return on Assets (ttm) | -3.83% |
| Return on Equity (ttm) | -36.43% |
Income Statement
| Revenue (ttm) | 448.07M HKD |
| Revenue Per Share (ttm) | 1.14 HKD |
| Quarterly Revenue Growth (yoy) | -39.10% |
| Gross Profit (ttm) | 262.7M HKD |
| EBITDA | -42111000 HKD |
| Net Income Avi to Common (ttm) | -120214000 HKD |
| Diluted EPS (ttm) | -0.29 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 75.83M HKD |
| Total Cash Per Share (mrq) | 0.19 HKD |
| Total Debt (mrq) | 503.16M HKD |
| Total Debt/Equity (mrq) | 194.8 HKD |
| Current Ratio (mrq) | 0.73 |
| Book Value Per Share (mrq) | 0.654 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 88.51M HKD |
| Levered Free Cash Flow (ttm) | 66.8M HKD |
Profile of PuraPharm Corporation Limited
| Country | Hong Kong |
| State | N/A |
| City | Tai Po |
| Address | Wireless Centre, Phase One |
| ZIP | N/A |
| Phone | 852 2840 1840 |
| Website | https://www.purapharm.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 663 |
PuraPharm Corporation Limited, an investment holding company, researches, develops, produces, and sells concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally. It operates through five segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers over the counter health products under the PuraGold, Oncozac, Haveron, and Immuzac names. It also provides Chinese medicine clinic management system for general clinic management; and operates Chinese medicine clinics under the Nong's name that provide Chinese medicine services and concentrated Chinese medicine granules products. In addition, the company engages in the plantation and trading of raw Chinese herbs; and manufacture and sale of traditional Chinese medicine decoction pieces. Further, it provides modernized Chinese medicine services, and Chinese medical diagnostic services. The company sells its products to hospitals, healthcare institutions, and medicine practitioners, as well as operates an online store. The company was founded in 1998 and is headquartered in Tai Po, Hong Kong.
Q&A For PuraPharm Corporation Limited Stock
What is a current 1498.HK stock price?
PuraPharm Corporation Limited 1498.HK stock price today per share is 0.79 HKD.
How to purchase PuraPharm Corporation Limited stock?
You can buy 1498.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PuraPharm Corporation Limited?
The stock symbol or ticker of PuraPharm Corporation Limited is 1498.HK.
Which industry does the PuraPharm Corporation Limited company belong to?
The PuraPharm Corporation Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does PuraPharm Corporation Limited have in circulation?
The max supply of PuraPharm Corporation Limited shares is 395.9M.
What is PuraPharm Corporation Limited Price to Earnings Ratio (PE Ratio)?
PuraPharm Corporation Limited PE Ratio is now.
What was PuraPharm Corporation Limited earnings per share over the trailing 12 months (TTM)?
PuraPharm Corporation Limited EPS is -0.27 HKD over the trailing 12 months.
Which sector does the PuraPharm Corporation Limited company belong to?
The PuraPharm Corporation Limited sector is Healthcare.